INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 177 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2015. The put-call ratio across all filers is 1.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $60,932,000 | -25.0% | 560,812 | +13.6% | 0.01% | -35.3% |
| Q3 2016 | $81,253,000 | +19.4% | 493,670 | +3.5% | 0.02% | +13.3% |
| Q2 2016 | $68,074,000 | +13.4% | 477,108 | +2.1% | 0.02% | +7.1% |
| Q1 2016 | $60,030,000 | -7.8% | 467,272 | +7.2% | 0.01% | -6.7% |
| Q4 2015 | $65,114,000 | -19.6% | 435,983 | -10.7% | 0.02% | -28.6% |
| Q3 2015 | $80,969,000 | -25.5% | 488,177 | +8.5% | 0.02% | -19.2% |
| Q2 2015 | $108,625,000 | -2.1% | 450,015 | +14.4% | 0.03% | -3.7% |
| Q1 2015 | $110,925,000 | +106.5% | 393,324 | +14.2% | 0.03% | +107.7% |
| Q4 2014 | $53,717,000 | +133.2% | 344,342 | +253.8% | 0.01% | +85.7% |
| Q3 2014 | $23,034,000 | +18.8% | 97,316 | +18.7% | 0.01% | +40.0% |
| Q2 2014 | $19,397,000 | -70.7% | 81,970 | -59.1% | 0.01% | -75.0% |
| Q1 2014 | $66,104,000 | +397.5% | 200,442 | +3.0% | 0.02% | +400.0% |
| Q4 2013 | $13,286,000 | -5.2% | 194,582 | -4.2% | 0.00% | -20.0% |
| Q3 2013 | $14,022,000 | +99.6% | 203,136 | +29.6% | 0.01% | +66.7% |
| Q2 2013 | $7,026,000 | – | 156,684 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 640,688 | $9,514,000 | 1.49% |
| CM Management, LLC | 45,000 | $668,000 | 0.50% |
| EULAV Asset Management | 660,000 | $9,801,000 | 0.26% |
| DLD Asset Management, LP | 225,200 | $3,346,000 | 0.24% |
| Virtus ETF Advisers LLC | 21,387 | $318,000 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 79,145 | $1,175,000 | 0.12% |
| Hennion & Walsh Asset Management, Inc. | 136,720 | $2,030,000 | 0.11% |
| ALTRINSIC GLOBAL ADVISORS LLC | 168,800 | $2,507,000 | 0.08% |
| Inspire Investing, LLC | 31,868 | $473,000 | 0.06% |
| DUALITY ADVISERS, LP | 51,196 | $760,000 | 0.06% |